Guardian Pharmacy Services, Inc. (GRDN) stock
GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30157% above fair value
$49.38−0.60 (-1.20%)
Close on Nov 12, 2026Market cap $3.13BP/E –Yield –
Guardian Pharmacy Services ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Guardian Pharmacy Services's ebitda for the twelve months ending Sep 30, 2026 was $117.60M, up 46.2% year over year. For fiscal 2025 it was $95.04M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.04M | – |
| FY2024 | Dec 31, 2024 | -$43.15M | -172.9% |
| FY2023 | Dec 31, 2023 | $59.18M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $31.00M | +39.7% |
| Q2 FY2026 | Jun 30, 2026 | $26.45M | +46.4% |
| Q1 FY2026 | Mar 31, 2026 | $23.65M | +29.4% |
| Q4 FY2025 | Dec 31, 2025 | $36.50M | +66.6% |
| Q3 FY2025 | Sep 30, 2025 | $22.19M | – |
| Q2 FY2025 | Jun 30, 2025 | $18.07M | -17.4% |
| Q1 FY2025 | Mar 31, 2025 | $18.27M | +44.1% |
| Q4 FY2024 | Dec 31, 2024 | $21.91M | +8.3% |
| Q3 FY2024 | Sep 30, 2024 | -$99.62M | – |
| Q2 FY2024 | Jun 30, 2024 | $21.88M | – |
| Q1 FY2024 | Mar 31, 2024 | $12.68M | – |
| Q4 FY2023 | Dec 31, 2023 | $20.24M | – |
See a number that looks wrong?